David Jack was the Director of Research and Development of Allen & Hanburys Ltd and then Glaxo Holdings plc from 1961 to 1987. His aim over all these years was to concentrate the companies’ research on inventing treatments for common diseases such as those affecting the respiratory, gastrointestinal and cardiovascular systems. Under his research direction, Glaxo became one of the most successful pharmaceutical companies in the world. Medicines that he invented—salbutamol, salmeterol, beclamethasone dipropionate and fluticasone propionate—revolutionized the treatment of bronchial asthma by cutting down the incidence of acute asthma attacks, preventing hospital admissions and reducing the death rate from the disease. He also invented ranitidine for the treatment of peptic ulcer, which became the best-selling pharmaceutical product in the world. He was also responsible for the invention of sumatriptan for the treatment of migraine and ondansetron for the prevention of radiotherapy-induced nausea. David Jack was one of the most successful inventors of new medicines in the twentieth century.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.